PAMM Foundation Outsources Laboratory Activities to Eurofins

Published on: 
In the Lab eNewsletter, Pharmaceutical Technology's In the Lab eNewsletter, June 2022, Volume 17, Issue 6

Eurofins partners with PAMM to strengthen laboratory services for the Dutch healthcare system.

Eurofins Scientific signed an agreement in May 2022 with Stichting PAMM Laboratoria voor Pathologie en Medische Microbiologie (PAMM), a medical microbiology and pathology laboratory diagnostics company in The Netherlands. The agreement will see PAMM outsource its laboratory activities to Eurofins.

Under the agreement, Eurofins will invest in the laboratory and in R&D, innovation, employee development, and job security. PAMM serves six hospitals in The Netherlands, including two top-rated clinical oncology centers, general practitioners, and independent treatment centers. The lab specializes in medical microbiology and pathology and was the first in The Netherlands to have implemented full digital pathology, according to a May 9, 2022 press release.

“We are very pleased to welcome PAMM and its team of outstanding specialists and laboratory technicians to the Eurofins Group. This agreement reinforces the Group’s broad innovative test offering to hospitals and practitioners in The Netherlands, strengthens Eurofins geographic offering in the clinical testing market, and enhances our ability to deploy the latest scientific advances to benefit patients,” said Gilles Martin, Eurofins CEO, in the press release.


Source: Eurofins